Endocrine Therapy in Breast Cancer: Making Sense of the ‘Word Salad’
About 80 percent of breast cancers express the estrogen receptor (ER). In ER-positive tumors, estrogen is the main driver...
About 80 percent of breast cancers express the estrogen receptor (ER). In ER-positive tumors, estrogen is the main driver...
From a joyous opening performance from the Preservation Hall All-Stars to a closing plenary that highlighted the full spectrum...
Accounting for less than 1 percent of all newly diagnosed cancers in the United States each year, sarcomas are...
For June, the editors of the AACR’s 10 journals chose to spotlight a characterization of an investigational KRAS inhibitor,...
Gregory J. Aune, MD, PhD, is a renowned pediatric oncologist with a powerful story. At age 16, he was...
Although childhood cancer is rare, it represents the leading cause of death by disease in children in developed countries....
From June 23-26, researchers from around the world will gather in Boston for the Third AACR International Meeting on...
Karriem Watson is a public health expert serving as chief engagement officer of the National Institutes of Health’s All...
As the first AACR Annual Meeting held in person after the pandemic was coming to a close, the last...
Since COVID-19 first began its siege on the world, much of our scientific knowledge about the disease—and its source...